Medicine Information
This product is a pharmaceutical. Information on use, preparation, and administration should only be considered in accordance with the package insert and the instructions of a healthcare professional.
IV Infusion Solutions
12.5 mg/5 mL
LEVOSARD
Each 5 mL vial contains Levosimendan 12.5 mg.
Levosimendan concentrate for solution for infusion, 5 mL: 12.5 mg, 1 vial. Concentrate for solution for infusion, 5 mL vial.
Product Features
- Levosimendan 12.5 mg / 5 mL
- 1 vial
- Concentrate for solution for infusion
- Store at 2–8°C; do not freeze
Usage Information
Indication on pack: short-term treatment of acute decompensated heart failure (ADHF) in patients with inadequate response to conventional therapy and requiring increased myocardial contractility. Read the package insert for full dosage, administration, contraindications, precautions and adverse effects. Protect from light. Store in an airtight container at 2–8°C. Do not freeze.
Ingredients
Each 5 mL vial contains Levosimendan 12.5 mg.
Warning
Important Warning: This product is a medicine. It must not be used without medical advice. Dose, route of administration and treatment duration must be determined by a healthcare professional.